
Sign up to save your podcasts
Or


He discusses the company's gene therapy approach to retinitis pigmentosa, Stargardt disease (which just had a pivotal cleared by FDA today), and geographic atrophy.
By BiotechTV4.3
66 ratings
He discusses the company's gene therapy approach to retinitis pigmentosa, Stargardt disease (which just had a pivotal cleared by FDA today), and geographic atrophy.

3,223 Listeners

1,902 Listeners

123 Listeners

324 Listeners

61 Listeners

9,960 Listeners

86 Listeners

34 Listeners

353 Listeners

19 Listeners

60 Listeners

514 Listeners

41 Listeners

0 Listeners

4 Listeners

2 Listeners

6 Listeners

46 Listeners